N-(4-((4-(3-(3-tert-Butyl-1-p-tolyl-1H-pyrazol-5-yl)ureido)-naphthalen-1-yloxy)methyl)yridin-2-yl)-2-morpholinoacetamide

ID: ALA3780667

PubChem CID: 45257075

Max Phase: Preclinical

Molecular Formula: C37H41N7O4

Molecular Weight: 647.78

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCc3ccnc(NC(=O)CN4CCOCC4)c3)c3ccccc23)cc1

Standard InChI:  InChI=1S/C37H41N7O4/c1-25-9-11-27(12-10-25)44-34(22-32(42-44)37(2,3)4)41-36(46)39-30-13-14-31(29-8-6-5-7-28(29)30)48-24-26-15-16-38-33(21-26)40-35(45)23-43-17-19-47-20-18-43/h5-16,21-22H,17-20,23-24H2,1-4H3,(H,38,40,45)(H2,39,41,46)

Standard InChI Key:  UBWALTPIDHCQBF-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 48 53  0  0  0  0  0  0  0  0999 V2000
   -5.1496    9.7745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4433   10.5353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1058   10.3665    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1606    8.2737    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4041   15.0360    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7101   14.2982    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7242   12.7983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4323   12.0361    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1262   12.7739    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1122   14.2739    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8669    7.5130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8757    6.0130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5812    5.2552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2777    5.9976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2688    7.4976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5634    8.2553    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5870    3.7544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2907    2.9981    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2964    1.4973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6111    0.7486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6111   -0.7486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2964   -1.4973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -0.7486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2964   -1.4973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5929   -0.7486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5929    0.7486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2964    1.4973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.7486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2907   -2.9981    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5870   -3.7544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6288   -3.1588    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5812   -5.2552    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0118   -7.4927    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4782   -7.8082    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2314   -6.5110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2305   -5.3938    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8775   -6.0115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8881   -8.4875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4375   -8.1268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8122  -10.6485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3087   -9.9292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3969   -9.2071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2681  -11.0095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0203  -11.5128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7218   -6.3581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4254   -7.3302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.2123   -5.2629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.9155   -6.2350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  5 10  1  0
  2  8  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 11 16  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 19 28  2  0
 23 28  1  0
 18 19  1  0
 29 30  1  0
 30 31  2  0
 30 32  1  0
 33 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  2  0
 33 37  1  0
 38 39  1  0
 38 41  2  0
 39 42  2  0
 40 42  1  0
 40 43  2  0
 41 43  1  0
 40 44  1  0
 33 38  1  0
 35 45  1  0
 32 37  1  0
 22 29  1  0
 17 18  1  0
 13 17  1  0
  4 11  1  0
 45 46  1  0
 45 47  1  0
 45 48  1  0
M  END

Associated Targets(Human)

MAPK12 Tchem MAP kinase p38 gamma (2776 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCK Tclin Tyrosine-protein kinase HCK (2743 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK14 Tchem MAP kinase p38 alpha (12866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 647.78Molecular Weight (Monoisotopic): 647.3220AlogP: 6.52#Rotatable Bonds: 9
Polar Surface Area: 122.64Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 3#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.20CX Basic pKa: 4.80CX LogP: 6.58CX LogD: 6.58
Aromatic Rings: 5Heavy Atoms: 48QED Weighted: 0.17Np Likeness Score: -1.77

References

1. Onions ST, Ito K, Charron CE, Brown RJ, Colucci M, Frickel F, Hardy G, Joly K, King-Underwood J, Kizawa Y, Knowles I, Murray PJ, Novak A, Rani A, Rapeport G, Smith A, Strong P, Taddei DM, Williams JG..  (2016)  Discovery of Narrow Spectrum Kinase Inhibitors: New Therapeutic Agents for the Treatment of COPD and Steroid-Resistant Asthma.,  59  (5): [PMID:26800309] [10.1021/acs.jmedchem.5b01029]

Source